INMD Chart
About

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 885.76M
Enterprise Value 338.65M Income 93.83M Sales 370.50M
Book/sh 10.78 Cash/sh 8.77 Dividend Yield —
Payout 0.00% Employees 660 IPO —
P/E 9.78 Forward P/E 9.10 PEG —
P/S 2.39 P/B 1.30 P/C —
EV/EBITDA 3.93 EV/Sales 0.91 Quick Ratio 8.55
Current Ratio 9.88 Debt/Eq 1.20 LT Debt/Eq —
EPS (ttm) 1.43 EPS next Y 1.54 EPS Growth -63.50%
Revenue Growth 6.10% Earnings 2026-04-28 ROA 6.88%
ROE 13.53% ROIC — Gross Margin 78.53%
Oper. Margin 25.03% Profit Margin 25.33% Shs Outstand 63.36M
Shs Float 55.79M Short Float 5.85% Short Ratio 3.30
Short Interest — 52W High 19.78 52W Low 13.14
Beta 2.17 Avg Volume 901.38K Volume 1.09M
Target Price $16.80 Recom Hold Prev Close $14.20
Price $13.98 Change -1.55%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$16.80
Mean price target
2. Current target
$13.98
Latest analyst target
3. DCF / Fair value
$11.11
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$13.98
Low
$15.00
High
$21.00
Mean
$16.80

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-17 main Canaccord Genuity Hold → Hold $15
2025-11-06 main UBS Neutral → Neutral $16
2025-10-10 main Canaccord Genuity Hold → Hold $16
2025-10-10 reit Needham Hold → Hold —
2025-07-30 reit Needham Hold → Hold —
2025-07-30 main Barclays Overweight → Overweight $21
2025-07-11 main Canaccord Genuity Hold → Hold $15
2025-04-30 main Barclays Overweight → Overweight $24
2025-04-29 main UBS Neutral → Neutral $16
2025-04-29 down BTIG Buy → Neutral —
2025-04-29 main Canaccord Genuity Hold → Hold $15
2025-04-28 reit Needham Hold → Hold —
2025-04-14 main Jefferies Hold → Hold $15
2025-04-14 reit Needham Hold → Hold —
2025-04-09 reit Needham Hold → Hold —
2025-02-05 main Barclays Overweight → Overweight $29
2025-02-04 main Needham Hold → Hold —
2025-01-09 main Barclays Overweight → Overweight $26
2024-10-31 reit Needham — → Hold —
2024-10-21 init Alliance Global Partners — → Buy $20
Insider Transactions

No recent insider transactions.

Financials
Line Item2025-12-312024-12-312023-12-312022-12-31
TaxEffectOfUnusualItems0.000.000.000.00
TaxRateForCalcs0.150.210.090.20
NormalizedEBITDA86.08M113.26M196.28M198.53M
NetIncomeFromContinuingOperationNetMinorityInterest93.83M181.28M197.92M161.52M
ReconciledDepreciation695.00K728.00K623.00K680.00K
ReconciledCostOfRevenue79.53M77.75M80.71M73.48M
EBITDA86.08M113.26M196.28M198.53M
EBIT85.39M112.53M195.66M197.85M
NetInterestIncome24.94M30.94M21.61M3.61M
InterestIncome24.94M30.94M21.61M3.61M
NormalizedIncome93.83M181.28M197.92M161.52M
NetIncomeFromContinuingAndDiscontinuedOperation93.83M181.28M197.92M161.52M
TotalExpenses285.11M282.29M296.39M256.42M
TotalOperatingIncomeAsReported85.39M112.53M195.66M197.85M
DilutedAverageShares80.60M85.95M85.40M86.02M
BasicAverageShares79.31M83.53M82.48M81.44M
DilutedEPS2.252.301.891.92
BasicEPS2.292.371.962.03
DilutedNIAvailtoComStockholders93.83M181.28M197.92M161.52M
NetIncomeCommonStockholders93.83M181.28M197.92M161.52M
NetIncome93.83M181.28M197.92M161.52M
MinorityInterests0.000.00-103.00K
NetIncomeIncludingNoncontrollingInterests93.83M181.28M197.92M161.52M
NetIncomeContinuousOperations93.83M181.28M197.92M161.52M
TaxProvision16.50M-37.81M19.35M39.95M
PretaxIncome110.33M143.47M217.27M201.47M
NetNonOperatingInterestIncomeExpense24.94M30.94M21.61M3.61M
InterestIncomeNonOperating24.94M30.94M21.61M3.61M
OperatingIncome85.39M112.53M195.66M197.85M
OperatingExpense205.58M204.53M215.68M182.93M
OtherOperatingExpenses-800.00K
ResearchAndDevelopment13.32M13.14M13.41M12.43M
SellingGeneralAndAdministration192.26M191.40M202.27M170.51M
SellingAndMarketingExpense180.58M181.37M193.04M160.58M
GeneralAndAdministrativeExpense11.69M10.03M9.23M9.93M
OtherGandA11.69M10.03M9.23M9.93M
GrossProfit290.97M317.07M411.34M380.79M
CostOfRevenue79.53M77.75M80.71M73.48M
TotalRevenue370.50M394.82M492.05M454.27M
OperatingRevenue370.50M394.82M492.05M454.27M
Line Item2025-12-312024-12-312023-12-312022-12-31
TreasurySharesNumber24.98M18.03M1.98M1.98M
OrdinarySharesNumber63.36M69.56M83.98M82.54M
ShareIssued88.33M87.58M85.96M84.52M
TotalDebt8.23M7.82M9.02M4.96M
TangibleBookValue683.20M703.81M787.37M554.62M
InvestedCapital683.20M703.81M787.37M554.62M
WorkingCapital627.88M644.60M781.19M547.35M
NetTangibleAssets683.20M703.81M787.37M554.62M
CapitalLeaseObligations8.23M7.82M9.02M4.96M
CommonStockEquity683.20M703.81M787.37M554.62M
TotalCapitalization683.20M703.81M787.37M554.62M
TotalEquityGrossMinorityInterest683.20M703.81M787.37M554.62M
MinorityInterest0.000.00
StockholdersEquity683.20M703.81M787.37M554.62M
GainsLossesNotAffectingRetainedEarnings69.00K-340.00K-1.68M-7.49M
TreasuryStock495.27M367.82M82.44M82.44M
RetainedEarnings968.53M874.70M693.43M495.51M
AdditionalPaidInCapital209.62M197.03M177.82M148.80M
CapitalStock251.00K249.00K245.00K241.00K
CommonStock251.00K249.00K245.00K241.00K
TotalLiabilitiesNetMinorityInterest83.23M81.85M75.91M89.79M
TotalNonCurrentLiabilitiesNetMinorityInterest12.49M12.00M11.78M7.77M
OtherNonCurrentLiabilities4.44M3.36M1.40M303.00K
NonCurrentDeferredLiabilities3.04M3.34M3.77M3.96M
NonCurrentDeferredRevenue3.04M3.34M3.77M3.96M
LongTermDebtAndCapitalLeaseObligation5.01M5.31M6.61M3.51M
LongTermCapitalLeaseObligation5.01M5.31M6.61M3.51M
CurrentLiabilities70.74M69.85M64.14M82.02M
OtherCurrentLiabilities15.96M16.04M10.97M10.43M
CurrentDeferredLiabilities12.09M16.75M10.92M13.80M
CurrentDeferredRevenue12.09M16.75M10.92M13.80M
CurrentDebtAndCapitalLeaseObligation3.22M2.51M2.40M1.45M
CurrentCapitalLeaseObligation3.22M2.51M2.40M1.45M
PensionandOtherPostRetirementBenefitPlansCurrent18.16M16.73M21.04M19.44M
CurrentProvisions931.00K722.00K1.48M1.42M
PayablesAndAccruedExpenses20.38M17.09M17.32M35.48M
CurrentAccruedExpenses1.71M2.38M1.44M
Payables18.67M14.71M15.88M35.48M
TotalTaxPayable761.00K933.00K1.92M19.24M
IncomeTaxPayable761.00K933.00K1.92M19.24M
AccountsPayable17.91M13.78M13.97M16.24M
TotalAssets766.43M785.67M863.29M644.41M
TotalNonCurrentAssets67.81M71.22M17.96M15.04M
NonCurrentDeferredAssets53.23M56.28M1.51M3.09M
NonCurrentDeferredTaxesAssets53.23M56.28M1.51M3.09M
NonCurrentAccountsReceivable3.00M3.18M3.67M3.97M
InvestmentsAndAdvances700.00K700.00K700.00K600.00K
OtherInvestments600.00K
LongTermEquityInvestment700.00K700.00K700.00K600.00K
InvestmentsInOtherVenturesUnderEquityMethod700.00K700.00K700.00K600.00K
NetPPE10.87M11.05M12.08M7.37M
AccumulatedDepreciation-4.88M-4.18M-3.46M-2.83M
GrossPPE15.75M15.24M15.54M10.21M
Leases1.42M1.33M1.24M829.00K
OtherProperties12.08M11.75M12.29M7.62M
MachineryFurnitureEquipment2.25M2.15M2.00M1.75M
Properties0.000.000.000.00
CurrentAssets698.62M714.45M845.33M629.37M
PrepaidAssets19.95M17.38M15.00M13.83M
Inventory74.05M59.55M45.09M39.90M
FinishedGoods46.86M44.09M33.02M26.21M
RawMaterials27.19M15.45M12.08M13.69M
Receivables49.28M41.05M43.63M28.27M
OtherReceivables1.83M3.29M1.20M1.22M
TaxesReceivable3.95M1.42M66.00K44.00K
AccountsReceivable43.50M36.34M42.36M27.00M
AllowanceForDoubtfulAccountsReceivable-2.37M-1.82M-1.54M-836.00K
GrossAccountsReceivable45.88M38.16M43.90M27.83M
CashCashEquivalentsAndShortTermInvestments555.33M596.47M741.61M547.38M
OtherShortTermInvestments252.79M441.14M597.19M449.84M
CashAndCashEquivalents302.54M155.33M144.41M97.54M
Line Item2025-12-312024-12-312023-12-312022-12-31
FreeCashFlow84.28M132.00M176.12M180.00M
RepurchaseOfCapitalStock-127.44M-285.38M0.00-42.64M
IssuanceOfCapitalStock0.00
CapitalExpenditure-972.00K-669.00K-705.00K-1.57M
IncomeTaxPaidSupplementalData14.87M17.69M31.61M25.84M
EndCashPosition302.54M155.33M144.41M97.54M
BeginningCashPosition155.33M144.41M97.54M68.14M
EffectOfExchangeRateChanges1.98M-1.18M605.00K-1.61M
ChangesInCash145.23M12.10M46.27M31.02M
FinancingCashFlow-126.06M-282.77M5.50M-41.09M
CashFlowFromContinuingFinancingActivities-126.06M-282.77M5.50M-41.09M
ProceedsFromStockOptionExercised1.39M2.61M5.50M1.55M
NetCommonStockIssuance-127.44M-285.38M0.00-42.64M
CommonStockPayments-127.44M-285.38M0.00-42.64M
CommonStockIssuance0.00
InvestingCashFlow186.03M162.21M-136.06M-109.47M
CashFlowFromContinuingInvestingActivities186.03M162.21M-136.06M-109.47M
NetInvestmentPurchaseAndSale187.00M162.88M-135.36M-107.90M
SaleOfInvestment500.52M667.28M343.32M154.48M
PurchaseOfInvestment-313.51M-504.41M-478.68M-262.38M
NetPPEPurchaseAndSale-972.00K-669.00K-705.00K-1.57M
PurchaseOfPPE-972.00K-669.00K-705.00K-1.57M
OperatingCashFlow85.26M132.66M176.83M181.58M
CashFlowFromContinuingOperatingActivities85.26M132.66M176.83M181.58M
ChangeInWorkingCapital-24.30M-7.07M-41.44M-4.47M
ChangeInOtherWorkingCapital-4.96M5.40M-3.07M1.20M
ChangeInOtherCurrentLiabilities2.16M1.92M-12.59M17.94M
ChangeInPayablesAndAccruedExpense4.13M-184.00K-2.28M7.46M
ChangeInAccruedExpense0.00
ChangeInPayable4.13M-184.00K-2.28M7.46M
ChangeInAccountPayable4.13M-184.00K-2.28M7.46M
ChangeInInventory-14.50M-14.45M-5.20M-18.87M
ChangeInReceivables-11.13M251.00K-18.31M-12.20M
ChangesInAccountReceivables-7.45M5.95M-16.08M-10.41M
OtherNonCashItems498.00K-4.40M-4.71M-1.21M
StockBasedCompensation11.13M16.57M23.60M24.45M
ProvisionandWriteOffofAssets454.00K572.00K1.02M449.00K
DeferredTax2.93M-55.18M-184.00K84.00K
DeferredIncomeTax2.93M-55.18M-184.00K84.00K
DepreciationAmortizationDepletion695.00K728.00K623.00K680.00K
DepreciationAndAmortization695.00K728.00K623.00K680.00K
Depreciation695.00K728.00K623.00K680.00K
OperatingGainsLosses15.00K167.00K71.00K175.00K
GainLossOnInvestmentSecurities15.00K167.00K71.00K175.00K
NetIncomeFromContinuingOperations93.83M181.28M197.92M161.52M
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Public Trades for INMD
Date User Asset Broker Type Position Size Entry Price Patterns